Chiral Separation Chromatography Columns Market By Type (Empty Columns and Pre-packed Columns), By Application (Academics, Agriculture Industry, Biotechnology, Environmental Biotechnology, and Pharmaceuticals), and By Region - Market Trends, Analysis, and Forecast till 2029

Chiral separation column is a technique in which two enantiomers of the same compound with different affinity are separated. The chiral separation is significant, because most of the bioorganic molecules in human body are chiral. It helps in developing technology for analysis and separation of racemic drugs in pharmaceutical industries. The preparation of pure optically active compounds and determination of reaction mechanism & pathways are carried out using chiral separation columns in laboratories.

Green chromatography based on techniques that help to reduce the use of reagents, solvents, and other chemicals, which are hazardous to the human health and environment positively enhance the global market in Asia Pacific. This has led to the introduction of the many new micro-scales, smaller, faster, chromatography instruments those are involved in solvent-saving techniques.

Demand from biotechnology and pharmaceutical industry and research

These industries are prime users of chromatography techniques. Furthermore, government bodies have extended their help in the form of investments, funds, and grants, which has stimulated the use of advanced chromatographic techniques in these industries. Also, research activities in medicines, proteomics, metabolomics, and genomics have propelled the use of chromatography instruments in these industries. Various factors such as innovations, incessant rise in new product launches, and rising number of conferences related to chromatography techniques are propelling the growth. According to data published in the Journal of the American Chemical Society the continued development of chiral separation techniques therefore remains a key research area. A team involving researchers from Kanazawa University has reported a three-state switchable chiral stationary phase (CSP) that provides new opportunities in chiral separation.

Rising government initiatives

The rising government support for financial spending on advanced features of chiral chromatography techniques and clinical research activities are further accelerating the market growth. Government bodies have extended their help in the form of investments, funds, and grants, which has stimulated the usage of advanced chromatographic techniques such as chiral chromatography. According to the report Servier CDMO, the contract development and manufacturing organization (CDMO) division of Servier, today announced that the company has invested $7.5 million USD in intensified technology including continuous chromatography with simulated moving bed (SMB) and super critical fluid chromatography (SFC) with solvent recycling of up to 90% to lower environmental impact. Servier CDMO expects at least a 50% increase in productivity in addition to the existing configuration of the high-volume batch columns that are used to manufacture drug substances. The investment will allow the chemical purification of 50kg (kilograms) per day, and the chiral separation of 10kg per day to support clinical trials and market supply upon drug approvals.

However, the high cost of chromatography systems and the need for skilled personnel to operate high-end systems are the major factors that hamper growth of the global market to a certain extent.

The global chiral separation chromatography columns market is segmented based on type, application, and region.

On the basis of type, the global chiral separation chromatography columns market is segmented into empty columns and pre-packed columns. Based on application, the global market is classified into academics, agriculture industry, biotechnology, environmental biotechnology, and pharmaceuticals.

Regional Insights:

On region the global chiral separation chromatography columns market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global chiral chromatography market. The U.S. represents the largest market for chiral chromatography followed by Canada in North America. However, Asia is expected to show high growth rates in the next five years in global chiral chromatography market due to increasing number of clinical research institutes, pharmaceutical and biotechnology companies. In addition, less stringent regulations also supports in the growth of chiral chromatography market in Asia. This has led to increase research activities in the region. China, India and Korea are expected to be the fastest growing chiral chromatography markets in Asia. For instance, a recent article on NPR (National Public Radio) in the USA discussed how chromatography helped a distillery recreate a whisky that was first distilled over a hundred years ago in Kentucky, USA. Chromatography is a powerful analytical technique that is probably more closely associated with developing new drugs or analyzing crime scene samples to help bring criminals to justice.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global chiral separation chromatography columns market report based on type, application, and region.

Global Chiral Separation Chromatography Columns Market, By Region:

• North America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • U.S.
  • Canada

The key players operating in the global chiral separation chromatography columns market includes Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Sigma Aldrich Corp., GE Healthcare, Inc., Shimadzu Corp., Phenomenex, Inc., and Waters Corp. Partnerships, expansions, collaborations, mergers & acquisitions, joint ventures, and others are some of the strategies adopted by these manufacturers to gain strong foothold in the market. For instance, in April 2020, DAICEL Corporation, the parent company of Arbor Biosciences, is providing their innovative drug delivery device, pyro-drive jet injector Actranza lab., for use in a joint partnership to develop a DNA vaccine against SARS-CoV-2, currently being conducted by Osaka University and Japanese company AnGes, Inc.

• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Sigma Aldrich Corp.
• GE Healthcare, Inc.
• Shimadzu Corp.
• Phenomenex, Inc.
• Waters Corp.